Adage Capital Partners’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-250,000
| Closed | -$3.65M | – | 1087 |
|
|
2020
Q4 | $3.65M | Buy |
+250,000
| New | +$3.65M | 0.01% | 717 |
|
|
2018
Q2 | – | Sell |
-300,000
| Closed | -$1.63M | – | 810 |
|
|
2018
Q1 | $1.63M | Sell |
300,000
-699,857
| -70% | -$3.81M | ﹤0.01% | 676 |
|
|
2017
Q4 | $4.17M | Sell |
999,857
-50,000
| -5% | -$208K | 0.01% | 638 |
|
|
2017
Q3 | $10.1M | Sell |
1,049,857
-350,000
| -25% | -$3.37M | 0.02% | 557 |
|
|
2017
Q2 | $16.6M | Sell |
1,399,857
-650,000
| -32% | -$7.69M | 0.04% | 454 |
|
|
2017
Q1 | $26.3M | Sell |
2,049,857
-200,000
| -9% | -$2.56M | 0.07% | 348 |
|
|
2016
Q4 | $27.5M | Sell |
2,249,857
-350,000
| -13% | -$4.28M | 0.08% | 315 |
|
|
2016
Q3 | $30.7M | Sell |
2,599,857
-100,000
| -4% | -$1.18M | 0.08% | 310 |
|
|
2016
Q2 | $23.5M | Buy |
2,699,857
+124,821
| +5% | +$1.09M | 0.06% | 336 |
|
|
2016
Q1 | $13.6M | Buy |
2,575,036
+350,000
| +16% | +$1.84M | 0.04% | 451 |
|
|
2015
Q4 | $17.3M | Buy |
2,225,036
+324,809
| +17% | +$2.52M | 0.05% | 412 |
|
|
2015
Q3 | $15M | Sell |
1,900,227
-118,930
| -6% | -$936K | 0.04% | 445 |
|
|
2015
Q2 | $18.3M | Buy |
2,019,157
+200,000
| +11% | +$1.81M | 0.05% | 428 |
|
|
2015
Q1 | $23.6M | Sell |
1,819,157
-6,070
| -0.3% | -$78.8K | 0.06% | 385 |
|
|
2014
Q4 | $24.8M | Buy |
1,825,227
+175,000
| +11% | +$2.38M | 0.06% | 357 |
|
|
2014
Q3 | $14.8M | Hold |
1,650,227
| – | – | 0.04% | 453 |
|
|
2014
Q2 | $22.3M | Buy |
1,650,227
+76,476
| +5% | +$1.03M | 0.06% | 371 |
|
|
2014
Q1 | $15.6M | Sell |
1,573,751
-43,196
| -3% | -$429K | 0.04% | 422 |
|
|
2013
Q4 | $21.5M | Buy |
1,616,947
+324,671
| +25% | +$4.31M | 0.06% | 380 |
|
|
2013
Q3 | $15.7M | Buy |
1,292,276
+691,248
| +115% | +$8.39M | 0.05% | 417 |
|
|
2013
Q2 | $6.22M | Buy |
+601,028
| New | +$6.22M | 0.02% | 566 |
|